Thank you for your interest in our activities! On the following pages you will find information about our aim, objectives, and current and past activities.
Eurartesim (Dihydroartemisinin/Piperaquin) a novel ACT has been licensed by the EMA (European Medicines Agency) in Nov. 2011. Eruartesim is licensed for the tre[more]
Due to the repeated importation of Measles to Ecuador the Ministry of Health has implemented a new regulation demanding obligatory vaccination proof for inter[more]
South Africa informed the WHO that it considered that travellers from countries with low risk of YF transmission still pose a risk of YF importation into the [more]
